| Project/Area Number |
23659052
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Nagoya Institute of Technology |
|---|
Principal Investigator |
SHLBATA Norio 名古屋工業大学, 工学研究科, 教授 (40293302)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 医薬品化学 / フッ素 / フタロシアニン / 抗がん剤 / 色素 / 光 / テトラゾール / 癌 / 医薬 / トリフルオロ / サブフタロシアニン |
|---|
| Research Abstract |
Designed and synthesis of a novel anti-cancer agent, trifluoroethoxyphthalocyanine-aminotetrazole conjugate (TFEO-Pc-AT) is described. The target compound was synthesized nicely by the use of copper-catalyzed Click-reaction of 1-(2-azidoethyl)-5-aminotetrazole and phthalocyanine containing terminal alkyne as a key step. TFEO-Pc-AT showed excellent photodynamic activities against B16-F10 murine melanoma upon illumination with a 660 nm laser, while no cytotoxicity of TFEO-Pc-AT was observed without illumination.
|
